ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Surgical Oncologists Honor HHS Secretary

March 22, 2002

Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority

September 14, 1979

Doctor-Patient Conversations At End of Life Associated With Lower Medical Expenses

March 27, 2009

In Brief: Scientist Bands Entertain Writers

December 19, 1997

NCAB to Get NCI Bypass Budget May 13; DeVita Tells Centers That Is Where “Our Philosophy Can Be Found”

May 3, 1985

ACCC To Consider Cancer Act Changes HSA Problems

January 7, 1977